Leerink Partnrs Issues Negative Forecast for TSBX Earnings
Turnstone Biologics Corp. (NASDAQ:TSBX – Free Report) – Stock analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of Turnstone Biologics in a research report issued to clients and investors on Tuesday, April 1st. Leerink Partnrs analyst D. Graybosch now forecasts that the company will earn ($0.26) per share […]
Turnstone Biologics Corp. (NASDAQ:TSBX – Free Report) – Stock analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of Turnstone Biologics in a research report issued to clients and investors on Tuesday, April 1st. Leerink Partnrs analyst D. Graybosch now forecasts that the company will earn ($0.26) per share […]
